Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

160 search results for ‘*’

Manufacture Technology and Equipment

Innovation Awards: Voting Closes January 28

Who will be the grand winner of our 2024 Innovation Awards?

Business & Regulation Standards & Regulation

Trump 2.0

| Stephanie Vine | 3 min read

Trump withdraws the US from the WHO and pharma stakeholders call for changes to price negotiation program

Discovery & Development Drug Delivery

Nanovesicles: An Approach to Improve Genetic Medicine

| 4 min read

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.

Discovery & Development Dosage Forms

Improving Transparency in HPMC Capsules

| Stephanie Vine

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

Business & Regulation Standards & Regulation

Regulatory Flexibility in the Event of A Pandemic

| Rob Coker | 3 min read

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.

Business & Regulation Standards & Regulation

EFPIA Calls For Clarity Over JCA Concerns

| Rob Coker | 2 min read

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

Manufacture Small Molecules

Small World

| Rob Coker | 5 min read

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

Business & Regulation Digital Technologies

AI and the Copyright Question for R&D

| Rob Coker | 2 min read

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

Discovery & Development Dosage Forms

A DNA-Based Method of Anticounterfeiting

| Stephanie Vine

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Business & Regulation Trends & Forecasts

Analyzing Access: Novartis is the New Leader in the 2024 Access to Medicine Index

| Rob Coker

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register